In a new action plan, the White House aims to boost the country’s AI innovation through deregulation, infrastructure ...

Detailed price information for Oncolytics Biotech Inc (ONCY-Q) from The Globe and Mail including charting and trades.

Detailed price information for Oncolytics Biotech Inc (ONCY-Q) from The Globe and Mail including charting and trades.

BeOne Medicines Ltd. (NASDAQ:ONC), formerly BeiGene, is a global oncology company now headquartered in Switzerland following its May 2025 redomiciliation.

Adjusted EBITDA for the quarter was $6.5 million, and the company reported adjusted net income of $3.3 million, or $0.07 per share, for Q2. Year-to-date GAAP net income totaled $4.9 million, with $55 ...

Sunwave Health, a leading provider of healthcare software solutions, today announced that its all-in-one platform has earned the prestigious ONC Health IT Certification from the Office of the National ...

A major milestone for BeOne Medicines Ltd. (NASDAQ:ONC) this year was the European Commission’s approval of Tevimbra (tislelizumab) for multiple indications, including extensive-stage small cell ...

Earning ONC Health IT Certification reinforces Sunwave’s long-standing commitment to privacy, data security, and interoperability. By meeting federally recognized standards, Sunwave affirms its role ...

ASTP has released a series of “Health Data, Technology, and Interoperability” (HTI) regulations over the last two years. The ...

“Kill the Clipboard” is the name of a 2025 white paper by Ryan Howells, a one-time contender to lead the ONC and a principal ...

For more than 10 years, Netsmart has been at the forefront of interoperability efforts, advocating for improved standards like the sharing of behavioral health and substance use data that meet the ...

Investing.com -- BeOne Medicines AG (NASDAQ: ONC) stock gained 2.5% in pre-market trading after the company announced a positive recommendation from the European Medicines Agency for its cancer drug ...